Get started
Author

Philippe Tangre

Observed names: P Tangre, P. Tangre, Philippe TANGRE
Institution: l'Assurance Maladie
ORCID: 0009-0003-9924-9075
Observed ORCID: 0009-0003-9924-9075
OpenAlex ID: A5037346966
Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure
2011 · Pierre Delobel, Adrien Saliou, et al. · PLoS ONE · 38
PDF
Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort
2025 · Guillaume Baudry, Ouarda Pereira, et al. · European Heart Journal · 35
PDF
Risk of Readmission and Death After Hospitalization for Worsening Heart Failure: Role of Post-Discharge Follow-up Visits in a Real-World Study from the Grand Est Region of France
2023 · Guillaume Baudry, Ouarda Pereira, et al. · European Journal of Heart Failure · 30
PDF
Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir
2004 · the NARVAL Trial Group (ANRS 088), Stephane Lastere, et al. · Antiviral Therapy · 21
PDF
Experience using MedDRA for global events coding in HIV clinical trials
2005 · Christine Tonéatti, Yacine Saïdi, et al. · Contemporary Clinical Trials · 16
Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial
2009 · Marie-Anne Bouldouyre, Isabelle Charreau, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 14
Sex-Based Differences in Heart Failure Management and Outcomes: Insights from the French-DataHF Cohort
2025 · Guillaume Baudry, Ouarda Pereira, et al. · European Journal of Heart Failure · 13
Presence of Lamivudine or Emtricitabine Is Associated with Reduced Emergence of Nonnucleoside Reverse Transcriptase Inhibitor Mutations in an Efavirenz-Based Intermittent Antiretroviral Treatment Regimen
2011 · Stéphanie Trancart, Isabelle Charreau, et al. · Antimicrobial Agents and Chemotherapy · 8
HIV-1-Resistant Strains during 8-Week on 8-Week off Intermittent Therapy and their Effect on CD4 + T-cell Counts and Antiviral Response
2008 · Jacques Izopet, Bruno Marchou, et al. · Antiviral Therapy · 8
PDF
Major Hypertriglyceridemia in HIV-Infected Patients on Antiretroviral Therapy: A Role of the Personal and Family History
2004 · D. Bollens, M. Guiguet, et al. · Infection · 4
Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection: A Substudy of the ANRS 106 Window Trial
2008 · Isabelle Charreau, Grégoire Jeanblanc, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 3
Évaluation médicoéconomique du PRADO-BPCO, programme d’accompagnement post-exacerbation
2024 · N. Roche, A. Caron, et al. · Revue des Maladies Respiratoires · 2
Prevalence, sociodemographic characteristics and spatial distribution of systemic lupus erythematosus in France: a nationwide study using health claims data with insights into hydroxychloroquine prescription patterns
2025 · Jacques Pouchot, Laurence Mandereau-Bruno, et al. · Lupus Science & Medicine · 1
PDF
Prognostic outcomes in heart failure based on simple severity criteria: Insights from the French national healthcare coverage database
2025 · G. Baudry, O. Pereira, et al. · Archives of cardiovascular diseases · 1
Réadaptation cardiaque (RC) post-infarctus à domicile versus en centre SMR : analyse cas-témoin du SNDS dans le cadre de l’expérimentation Article 51 Walk’hop
2026 · Solenne TAUTY, Marie-Michelle SIX, et al. · Journal of Epidemiology and Population Health
Impact économique d’un parcours innovant combinant une diversification des modalités de séjour de RR et un suivi post-RR : Comparaison sur données SNDS de l’expérimentation Article 51 Inspir’Action à un parcours de RR classique
2026 · Louis CHILLOTTI, Nelly HERAUD, et al. · Journal of Epidemiology and Population Health
Approche alternative à la réadaptation cardiaque (RC) dans la prise en charge de la maladie coronarienne : analyse SNDS cas-témoin comparant la RC classique et la prise en charge par des structures libérales légères (SLL) créées par l’expérimentation Article 51 SLL-Marcadet
2026 · Louis CHILLOTTI, Dany-Michel MARCADET, et al. · Journal of Epidemiology and Population Health
Sex-based differences in heart failure management and outcomes: Insights from the French-DataHF cohort
2026 · B. Baudry, O. Pereira, et al. · Archives of cardiovascular diseases
L’optimisation du parcours de soins des patients IC dans les territoires : l’initiative Outil’IC
2025 · Philippe Tangre · Soins
Real-world data on management intensity and medical follow-up in heart failure: Insights from the French national healthcare coverage database
2025 · G. Baudry, O. Pereira, et al. · Archives of cardiovascular diseases
Healthcare resource utilization and prognosis after heart failure decompensation according to gender. Insight from SNDS database
2023 · G. Baudry, O. Pereira, et al. · Archives of cardiovascular diseases
Healthcare consumption, readmission and death rates after heart failure hospitalization: Insights from reimbursement databases of the France Grand Est region
2022 · N. Girerd, O. Pereira, et al. · Archives of Cardiovascular Diseases Supplements
Pin32 Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled Hiv Infection.a Substudy of the Anrs 106 Window Trial
2008 · I Charreau, G Jeanblanc, et al. · Value in Health
PDF
La qualité de vie (QDV) des patients infectés par le VIH : comparaison des données obtenues dans deux essais cliniques (Window ANRS 106 et Interstart ANRS 119) avec celles de l’enquête nationale représentative « VESPA » (ANRS EN12) et de la population générale française (Insee 2003)
2008 · M. Hanf, I. Charreau, et al. · Revue d Épidémiologie et de Santé Publique
Works count: 24
Citation count: 194
H-index: 8
I10-index: 7
Year
Topic
Type